Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Eyeing Response to U.S. Recommendation to Impose Sanctions on Russian Titanium, Palladium

The United States recently called on its Group of Seven (“G7”) allies to consider imposing sanctions on Russian titanium and palladium supplies, a move that, if approved, could have a profound impact on global metals markets as well as on Russia’s economy (https://ibn.fm/Q9sHS). Companies operating in the metals sector, including Platinum Group Metals (NYSE American: […]

Report: Robots Are Revolutionizing Hospitality; Nightfood Holdings Inc.’s (NGTF) Game-Changing Automation Gameplan Revealed

As hospitality businesses grapple with labor shortages and rising operational costs, a single stark reality has set in:  automate or die. According to the International Federation of Robotics (“IFR”), two industries are spearheading the adoption of robotics: logistics and hospitality. The Germany-based organization’s recent report on the industry showed sales surged 30% globally to more […]

Annovis Bio Inc. (NYSE: ANVS) Gets FDA Clearance for Buntanetap Pivotal Phase 3 Trials, Market Enthusiasm Highlighted in GuruFocus Article

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently secured the approval of the U.S. Food and Drug Administration (“FDA”) to pursue Phase 3 clinical trials for lead Alzheimer’s drug candidate buntanetap. This important milestone, along with recent […]

D-Wave Quantum Inc. (NYSE: QBTS) Discusses Quantum Optimization, Presents Customer Success Stories at 2024 INFORMS Annual Meeting

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently participated in the 2024 INFORMS Annual Meeting, highlighting its quantum optimization solutions and customer success stories. INFORMS is the largest professional association for the decision and data sciences, encompassing a diverse range […]

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Making ‘Significant Strides’ in Promising Black Sea Region

In recent years, the Black Sea has emerged as a critical region for natural-gas exploration and development. As Europe seeks to diversify its energy sources, reduce dependency on Russian natural gas and transition to cleaner energy solutions, the untapped resources in the Black Sea offer a significant opportunity. Trillion Energy International (CSE: TCF) (OTCQB: TRLEF), […]

The MoneyShow Alternative Investing Virtual Expo

Market conditions no longer favor just one type or style of investing. That’s a key reason why MoneyShow is hosting the Alternative Investing Virtual Expo from Nov. 12, 2024, to Nov. 14, 2024. Traders and investors will gather to learn about alternative strategies and recommendations for the year ahead. Specifically, attendees can connect with distinguished […]

 

From Our Blog

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial

June 26, 2025

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with advanced non-small cell lung cancer (“NSCLC”) achieved a complete response using LP-300, a compound optimized through Lantern’s AI-powered platform, RADR(R) […]

Rotate your device 90° to view site.